Boehringer raises hope of diabetic macular ischaemia therapy
Boehringer Ingelheim says it may have found the first therapy for …
Newsletters and Deep Dive digital magazine
Boehringer Ingelheim says it may have found the first therapy for …
The Novo Nordisk Foundation, the Bill & Melinda Gates Foundation, and …
The atrial fibrillation (AFib) detection feature on Apple Watch …
It has been nearly two years since Pfizer’s sickle cell disease (SCD) …
An artificial intelligence-powered home healthcare model that aims to …
One key aspect of the biospecimen market (if not the most important) …
Walgreens’ plans to disrupt the clinical trials sector have taken a …
Novartis has struck another deal to strengthen its position in …
Security and privacy within biotech are critical points of …
Good Clinical Practice (GCP), the bedrock of ethical and high-quality …
Hospital staff in the UK have developed and piloted an app that can …
A personalised vaccine for the aggressive and fatal brain cancer …
Spectral AI is on the brink of becoming a commercial-stage company, with the first sales of its DeepView wound imaging system due to start in its first market, the UK, lat
Explore “Innovation as Strategy” framework, providing a guide for employing innovative strategies in life sciences.
In this edition of Deep Dive, Unpacking complex choreography in the biologics patent dance, Alexion examines the urgent need for accelerated access programmes for rare disease treatments, and Putna
It will come as no surprise to anyone in the healthcare space that doctors today are under an inordinate amount of pressure.
We are living in an era of unprecedented advances in cancer treatments with transformative therapies being regularly approved.
The PM Society and Word Monster are joining forces in a new partnership focusing on raising standards and nurturing talent in the MedComms industry.
Accelerate your capsid and payload design with the 4th Next Generation Gene Therapy Vectors Summit (June 12-14, Boston), the industry’s only hub for covering the latest advances and innovations in